

ABSTRACT

ONE TERMINAL GROUP ARE EFFECTIVE IN THE TREATMENT OF UNGULATE MASTITIS, PARTICULARLY USEFUL IS 1,3 BUTYLENE GLYCOL (1,3-BG) WHICH IS ASMINISTERED IN PHARMACOLOGICALLY EFFECTIVE DOSES.

DEFENEiii/E PUBLWATIQN UNITED STATES PATENT AND TRADEMARK OFFICE Published at the request of the applicant or owner in accordance with the Notice of Dec. 16, 1969, 869 O.G. 687. The abstracts of Defensive Publication applications are identified by distinctly numbered series and arearrangecl chronologically. The heading of each abstract indicates the number of pages of specification, including claims and sheets of drawings contained in the application as originally filed. The files of these applicalions' are available to the public for inspection and reprofiuction may be purchased for 30 cents a sheet.

i Defensive Publication applicationshave not been examined as to the merits of alleged invention. The Patent and Trademark Ofiice makes no assertion as to the novelty of the disclosed subject matter.

PUBLISHED AUGUST 5, 1975 T937,002 TREATll/IENT 0F MASTITIS Norman G. Baker, 169 Van Houten Ave, Wyckofl, NJ. 07481 Continuation of abandoned application Ser. No. 279,607, Aug. 10, 1972. This application Oct. 23, 1973, Ser. 

